Exelixis (EXEL) Operating Expenses (2010 - 2026)
Exelixis (EXEL) recorded quarterly Operating Expenses of $359.5 million in Q2 2026, down 1.09% quarter-over-quarter from $363.4 million in Q1 2026, and down 2.47% on a YoY basis from $368.6 million in Q2 2025.
Exelixis (EXEL) Operating Expenses (2010 - 2026) Analysis & Trends
Exelixis' Operating Expenses history runs 17 years deep, the most recent figure standing at $359.5 million for Q2 2026.
- In Q2 2026, Operating Expenses fell 2.47% year-over-year to $359.5 million; the TTM figure through Apr 2026 stood at $1.4 billion (down 6.38% YoY), while the FY2026 annual figure was $1.4 billion, down 7.43% from the prior year.
- Operating Expenses was $359.5 million for Q2 2026 at Exelixis, down from $363.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $489.5 million in Q3 2023 to a low of $272.7 million in Q2 2022.
- Historically, Operating Expenses has averaged $378.8 million across 5 years, with a median of $368.6 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 48.73% in 2023, then decreased 17.58% in 2024.
- A 5-year view of Operating Expenses shows it stood at $472.0 million in 2022, then retreated by 15.71% to $397.9 million in 2023, then gained by 1.41% to $403.5 million in 2024, then slipped by 10.47% to $361.2 million in 2025, then fell by 0.48% to $359.5 million in 2026.
- The last three Operating Expenses figures came in at $359.5 million (Q2 2026), $363.4 million (Q1 2026), and $361.2 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -67.40 Mn |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 359.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 359.47 Mn |
| Jan 2, 2026 | 363.45 Mn |
| Oct 3, 2025 | 361.22 Mn |
| Jul 4, 2025 | 354.69 Mn |
| Apr 4, 2025 | 368.59 Mn |
| Jan 3, 2025 | 403.55 Mn |
| Sep 27, 2024 | 403.47 Mn |
| Jun 28, 2024 | 361.30 Mn |
| Mar 29, 2024 | 395.76 Mn |
| Dec 29, 2023 | 397.86 Mn |
| Sep 29, 2023 | 489.50 Mn |
| Jun 30, 2023 | 392.00 Mn |
| Mar 31, 2023 | 379.96 Mn |
| Dec 30, 2022 | 472.00 Mn |
| Sep 30, 2022 | 329.13 Mn |
| Jul 1, 2022 | 335.72 Mn |
| Apr 1, 2022 | 272.74 Mn |
| Dec 31, 2021 | 334.50 Mn |
| Oct 1, 2021 | 276.80 Mn |
| Jul 2, 2021 | 262.17 Mn |